Christopher Cabell Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Cabell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Cabell. Christopher Cabell is EVP, Head of R&D, and CMO in ARENA PHARMACEUTICALS INC ($ARNA) and Director in Pulmatrix, Inc. ($PULM).
Latest Insider Trading Transactions of Christopher Cabell
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | PULM | Pulmatrix, Inc. | Cabell Christopher | Director | Option Exercise | A | 1.47 | 15,000 | 22,050 | 15,000 | |
| Feb 01 2021 | PULM | Pulmatrix, Inc. | Cabell Christopher | Director | Option Exercise | A | 1.47 | 15,000 | 22,050 | 15,000 | |
| Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Payment of Exercise | F | 65.50 | 1,099 | 71,985 | 1,401 | 2.5 K to 1.4 K (-43.96 %) |
| Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Buy | M | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Jul 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Option Exercise | M | 26.28 | 13,000 | 341,640 | 47,000 | |
| Jul 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Sell | S | 68.00 | 13,000 | 884,000 | 0 | 13 K to 0 (-100.00 %) |
| Jul 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Buy | M | 26.28 | 13,000 | 341,640 | 13,000 | 0 to 13 K |
| Jun 25 2020 | PULM | Pulmatrix, Inc. | Cabell Christopher | Director | Option Exercise | A | 1.95 | 30,000 | 58,500 | 30,000 | |
| Jun 25 2020 | PULM | Pulmatrix, Inc. | Cabell Christopher | Director | Option Exercise | A | 1.95 | 30,000 | 58,500 | 30,000 | |
| Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Option Exercise | A | 61.31 | 20,000 | 1,226,200 | 20,000 |
Page: 1